Time- and passage-dependent characteristics of a Calu-3 respiratory epithelial cell model.
about
Bioelectric and Morphological Response of Liquid-Covered Human Airway Epithelial Calu-3 Cell Monolayer to Periodic Deposition of Colloidal 3-Mercaptopropionic-Acid Coated CdSe-CdS/ZnS Core-Multishell Quantum DotsPermeation of Therapeutic Drugs in Different Formulations across the Airway Epithelium In VitroIn vitro exposure system for study of aerosolized influenza virusPolymeric nanocarriers for transport modulation across the pulmonary epithelium: dendrimers, polymeric nanoparticles, and their nanoblendsDendrimer nanocarriers for transport modulation across models of the pulmonary epithelium.Dry powder formulation of simvastatin.Biological Effects of Simvastatin Formulated as pMDI on Pulmonary Epithelial Cells.Development of three-dimensional lung multicellular spheroids in air- and liquid-interface culture for the evaluation of anticancer therapeutics.Pharmaceutical applications of the Calu-3 lung epithelia cell line.Highly respirable dry powder inhalable formulation of voriconazole with enhanced pulmonary bioavailability.The effect of cell passage number on osteogenic and adipogenic characteristics of D1 cellsInhalable Clarithromycin Microparticles for Treatment of Respiratory Infections.Immunomodulatory effects of a low-dose clarithromycin-based macrolide solution pressurised metered dose inhaler.In vitro cell integrated impactor deposition methodology for the study of aerodynamically relevant size fractions from commercial pressurised metered dose inhalers.A microdevice for parallelized pulmonary permeability studies.Fluticasone uptake across Calu-3 cells is mediated by salmeterol when deposited as a combination powder inhaler.Ciprofloxacin is actively transported across bronchial lung epithelial cells using a Calu-3 air interface cell model.Drug delivery characteristics of the progenitor bronchial epithelial cell line VA10.Liposomal nanoparticles control the uptake of ciprofloxacin across respiratory epithelia.Modification of disodium cromoglycate passage across lung epithelium in vitro via incorporation into polymeric microparticles.Epithelial profiling of antibiotic controlled release respiratory formulations.Combined inhaled salbutamol and mannitol therapy for mucus hyper-secretion in pulmonary diseases.Aerosolization, Drug Permeation and Cellular Interaction of Dry Powder Pulmonary Formulations of Corticosteroids with Hydroxypropyl-β-Cyclodextrin as a Solubilizer.Inhaled simvastatin nanoparticles for inflammatory lung disease.Modelling upper respiratory tract diseases: getting grips on host-microbe interactions in chronic rhinosinusitis using in vitro technologies.Deposition and transport of linezolid mediated by a synthetic surfactant Synsurf® within a pressurized metered dose inhaler: a Calu-3 model.Models and On-Chip Systems: Biomaterial Interaction Studies With Tissues Generated Using Lung Epithelial and Liver Metabolic Cell Lines
P2860
Q28387984-7F67AEFA-FEDE-46E7-897C-A2A3BD19875AQ28547301-63E6E922-C839-4A06-9ECA-65117A02AE12Q29048607-152B3198-2003-4C48-BC09-C47465603760Q33574188-6527ED62-6FDA-4DFF-8F7A-C790F32454CDQ35150539-F95DEFC7-52E8-4244-9EF4-6AF2E46FD451Q35269057-7771FA9A-6FF4-4628-A14D-93F3F48633DEQ35735440-6A72F692-95C9-4C91-B1BE-BE4C104052C7Q36649540-AF27DC6A-7002-4BC4-A586-827CA3CD97A2Q38111427-4FA6A08F-A297-4233-9C6C-C500B4C17BE8Q38816463-3BF43ED7-D8CF-4E6F-BCBB-6544F8CF6B7CQ38849540-43A869BB-6D52-49AA-B18C-4D8F6ADEDA9CQ38859870-00E86F0D-F4D2-4F2D-9097-FB29A9C14651Q38925706-52E16C18-DDE4-474D-A2C8-3F5D9AABCBF6Q39022790-77A1C9E4-DC77-4A36-B6F0-25E7C2226C65Q39043463-5E33FBFC-10A4-4F0C-9837-996A1C2FB55CQ39135769-6FA0A25D-39A1-41B5-8978-08ADC7C5605AQ39178955-6FE93485-AC58-4D02-8410-D16DD1E9262EQ39248004-39CAB57C-3FCF-49DA-B23E-B582384F6B62Q39308123-49D72999-565D-45C2-820A-007E83FCF4E9Q39421517-2A667BF2-86DE-4E5C-9B1C-8D6698D47660Q39536127-5967F0E6-CBA5-411E-9EF6-74FFCDE6ABA8Q41975470-7F120183-54E4-4A31-9221-B7687F246523Q46492352-88A2A8BB-DA92-4FA5-91A5-70DCCB281939Q47755402-C9BCED47-05EF-4D37-9094-8440B134FAFCQ54940368-79271CBC-1974-480C-864E-ADE7C00F8CADQ54942350-CCB12716-C9F1-47EF-A53E-F0D057C22A44Q57161670-4232BA54-9B15-4FB7-B869-4DD09A10CCE4
P2860
Time- and passage-dependent characteristics of a Calu-3 respiratory epithelial cell model.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Time- and passage-dependent ch ...... iratory epithelial cell model.
@en
Time- and passage-dependent ch ...... iratory epithelial cell model.
@nl
type
label
Time- and passage-dependent ch ...... iratory epithelial cell model.
@en
Time- and passage-dependent ch ...... iratory epithelial cell model.
@nl
prefLabel
Time- and passage-dependent ch ...... iratory epithelial cell model.
@en
Time- and passage-dependent ch ...... iratory epithelial cell model.
@nl
P2860
P50
P1476
Time- and passage-dependent ch ...... iratory epithelial cell model.
@en
P2093
Joyce Gong
Paul M Young
P2860
P304
P356
10.3109/03639041003695113
P407
P577
2010-10-01T00:00:00Z